Sulglicotide: Difference between revisions
Created page with "{{Drugbox | Verifiedfields = changed | verifiedrevid = 470474395 | IUPAC_name = | image = Sulglicotide.svg | width = 350px <!--Clinical data--> | tradename = | Drugs.com..." |
No edit summary |
||
| Line 3: | Line 3: | ||
| verifiedrevid = 470474395 | | verifiedrevid = 470474395 | ||
| IUPAC_name = | | IUPAC_name = | ||
| image = Sulglicotide. | | image = Sulglicotide.png | ||
| width = 350px | | width = 350px | ||
| Line 43: | Line 43: | ||
| molecular_weight = | | molecular_weight = | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview=='''Sulglicotide''' (or '''sulglycotide''') is a [[drug]] used for [[peptic ulcer]] and [[Gastroesophageal reflux disease|gastro-oesophageal reflux disease]].<ref name="pmid11016862">{{cite journal |author=Slomiany BL, Piotrowski J, Slomiany A |title=Omeprazole fails to suppress up-regulation of gastric mucosal endothelin-converting enzyme-1 by Helicobacter pylori lipopolysaccharide |journal=J. Physiol. Pharmacol. |volume=51 |issue=3 |pages=421–31 |date=September 2000 |pmid=11016862 |doi= |url=http://www.jpp.krakow.pl/journal/archive/0900/pdf/421_0900_article.pdf}}</ref> | |||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
{{Drugs for peptic ulcer and GORD}} | {{Drugs for peptic ulcer and GORD}} | ||
[[Category: | [[Category:Drug]] | ||
Revision as of 20:50, 14 April 2015
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| CAS Number | |
| ChemSpider | |
| KEGG | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
  (what is this?) (verify) | |
|
WikiDoc Resources for Sulglicotide |
|
Articles |
|---|
|
Most recent articles on Sulglicotide Most cited articles on Sulglicotide |
|
Media |
|
Powerpoint slides on Sulglicotide |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Sulglicotide at Clinical Trials.gov Clinical Trials on Sulglicotide at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Sulglicotide
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Sulglicotide Discussion groups on Sulglicotide Patient Handouts on Sulglicotide Directions to Hospitals Treating Sulglicotide Risk calculators and risk factors for Sulglicotide
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Sulglicotide |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ==Overview==Sulglicotide (or sulglycotide) is a drug used for peptic ulcer and gastro-oesophageal reflux disease.[1]
References
- ↑ Slomiany BL, Piotrowski J, Slomiany A (September 2000). "Omeprazole fails to suppress up-regulation of gastric mucosal endothelin-converting enzyme-1 by Helicobacter pylori lipopolysaccharide" (PDF). J. Physiol. Pharmacol. 51 (3): 421–31. PMID 11016862.
- Pages with script errors
- CS1 maint: Multiple names: authors list
- Template:drugs.com link with non-standard subpage
- Articles with changed CASNo identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Infobox drug tracked parameters
- Drug